A novel approach to treat polycystic ovarian syndrome (PCOS) patients
نویسندگان
چکیده
The precise underlying pathophysiology for the progression of Polycystic Ovary Syndrome (PCOS) remains unclear. Eminent scientists and clinicians normally target given clinical symptoms to curtail syndrome in a period. For years, multiple varied techniques have been developed followed treat this disorder. A novel non-invasive, pain-free treatment ‘Neurotherapy’ has highlighted article that can be considered as boon field healing. This study aimed evaluate effectiveness Neurotherapy patient with PCOS. regular case PCOS ultrasonography denoting bilateral ovarian cysts is hereby discussed. Post therapy, ultrasound reports shown no trace both ovaries thereby concluding therapy very fruitful treating one most common gynaecology related female problems, without any side effects or after-effects.
منابع مشابه
SHBG and polycystic ovarian syndrome (PCOS)
Sex hormone binding globulin (SHBG) is a protein that binds to both testosterone and estradiol. Its amount can vary widely in patients, and if the SHBG is either low or high, the amount of active (bioavailable) testosterone can vary widely. Therefore, it is very important to measure SHBG in all patients being evaluated for polycystic ovarian syndrome, as well as other patients such as patients ...
متن کاملPhytotherapy for Polycystic Ovarian Syndrome (PCOS)
Polycystic ovarian syndrome (PCOS), also known as SteinLeventhal syndrome, is a common gynecological disorder characterized by hypergonadotrophism, hirsutism, obesity, oligomenorrhea and commonly associated with infertility. PCOS is a complex clinical picture and presents a multifaceted etiology related to imbalance of the hypothalamic-pituitary-adrenal (HPA) axis, thyroid involvement and metab...
متن کاملCardiovascular risk in women with polycystic ovarian syndrome (PCOS)
Aims: Studies have suggested that polycystic ovary syndrome (PCOS) is associated with increased cardiovascular risk. The aim of this study was to examine cardiovascular risk profiles in women with PCOS compared with healthy age and weight matched control subjects using novel biochemical and biophysical markers. Methods: After ethics committee approval, 11 women with PCOS and 12 controls were re...
متن کاملMicroRNAs Related to Polycystic Ovary Syndrome (PCOS)
Polycystic ovary syndrome (PCOS) is the most common, though heterogeneous, endocrine aberration in women of reproductive age, with high prevalence and socioeconomic costs. The syndrome is characterized by polycystic ovaries, chronic anovulation and hyperandrogenism, as well as being associated with infertility, insulin resistance, chronic low-grade inflammation and an increased life time risk o...
متن کاملI-37: Pathogenesis of PCOS and N AcetyCysteine, A Novel Remedy for Poly Cystic Ovarian Syndrome
Background: Poly cystic ovarian syndrome (PCOS) is the most prevalent endocrinopathy among women and the most common underlying diagnosis for anovulatory infertility. The role of insulin-resistance (IR) and hyperinsulinemia in pathophysiology and clinical manifestations of the syndrome depicts the importance of evaluation of the efficacy of insulin reducing medications. N acetyl cysteine (NAC) ...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Biomedicine
سال: 2022
ISSN: ['2211-8020', '2211-8039']
DOI: https://doi.org/10.51248/.v42i4.1503